Additionally, novel biomarkers were detected in neutrophil activation pathways that were highly upregulated in the severe COVID-19 group compared to healthy controls, including CD177, CEACAMs, MMP8, ELANE, OLFM4, Gal-9, DEFAs, and MPO [117,118]. Here, LGALS9 is linked to COVID-19.